Journal of Drugs in Dermatology

Legal Issues in Aesthetic Dermatology: What Dermatologists Should Know
Aesthetic DermatologyNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Mathew M. Avram  (Director of the Mass General Dermatology Laser & Cosmetic Center and Director of Dermatologic Surgery at MGH, as well as Faculty Director for Procedural Training in Harvard Medical School's Dermatology Department), who discusses potential legal situations that may ari …
Aesthetic Dermatology
Laboratory Testing in Telogen Effluvium
Telogen Effluvium (TE) Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. INTRODUCTION Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities …
Telogen Effluvium (TE)
JDD Issue Highlights | March 2022
The March 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from acne and psoriasis to Platelet Rich Plasma (PRP) for scarring alopecia and racial differences and their impact on treatment for hidradenitis suppurativa, we share this month’s issue highlights straight from the JDD Editor’s de …
Gender-Neutral Language in Aesthetic Dermatology | Cheat Sheet
aesthetic dermatologyDermatologists should adopt gender-neutral language in interactions with aesthetic patients, according to “A Genderfluid Approach to Aesthetic Language in Dermatology” by Marc Beuttler, MD, and Jennifer MacGregor, MD, published in the Journal of Drugs in Dermatology in January 2022. Gender-neutral language helps dermatologists prevent psychological upset or offense for patients with nonbinary …
aesthetic dermatology
What’s New in Atopic Dermatitis
atopic dermatitisNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology who serves as Associate Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about the latest in Atopic Dermatitis (AD). Watch as he discu …
atopic dermatitis